Cas:211320-77-3 4-Chloro-7,8-dimethoxyquinazoline manufacturer & supplier

We serve Chemical Name:4-Chloro-7,8-dimethoxyquinazoline CAS:211320-77-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Chloro-7,8-dimethoxyquinazoline

Chemical Name:4-Chloro-7,8-dimethoxyquinazoline
CAS.NO:211320-77-3
Synonyms:4-chloro-7,8-dimethoxy-quinazoline;a4578
Molecular Formula:C10H9ClN2O2
Molecular Weight:224.644
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:345.5±37.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.605
PSA:44.24000
Exact Mass:224.035248
LogP:1.42

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-chloro-7,8-dimethoxy-quinazoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,a4578 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-chloro-7,8-dimethoxy-quinazoline Use and application,4-chloro-7,8-dimethoxy-quinazoline technical grade,usp/ep/jp grade.


Related News: A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus. 4-Chloro-7,8-dimethoxyquinazoline manufacturer The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood. 4-Chloro-7,8-dimethoxyquinazoline supplier Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress. 4-Chloro-7,8-dimethoxyquinazoline vendor In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. 4-Chloro-7,8-dimethoxyquinazoline factory Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.